Sleep Disorders Trial, Recruiting NCT07086742 Sponsor: Pathway Medtech, LLC. Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07086742
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are generally healthy, with no major health conditions or only minor ones (classified as ASA health score I or II — confirm with trial site if unsure what this means)
  • People aged 18 to 65 years old
  • People who have agreed to take part and are willing to follow the study's procedures

Who may not be able to join:

  • People who smoke heavily or who have been exposed to high levels of carbon monoxide, leading to raised levels of a substance called carboxyhemoglobin in their blood
  • People with conditions that cause raised levels of methemoglobin (a form of hemoglobin) in their blood
  • People whose blood oxygen levels are low (below 95% when breathing normal air)
  • People with severe claustrophobia (strong fear of enclosed spaces)
  • People with a known history of altitude sickness
  • People with a body mass index (BMI) of 35 or higher
  • People with a known history of moderate to severe heart, lung, kidney, or liver disease
  • People diagnosed with moderate to severe asthma
  • People with inherited blood conditions affecting hemoglobin, such as sickle cell anemia or thalassemia, where the trial doctor considers this would make participation unsuitable
  • People with any other serious ongoing illness
  • People who have an injury, deformity, or skin abnormality at the locations where monitoring sensors would be placed, if the trial doctor believes this would affect the devices' accuracy
  • People with a history of fainting or vasovagal episodes (a type of fainting response)
  • People with a known sensitivity or allergy to local anesthetics or disinfectants (where these are used in the study)
  • People diagnosed with Raynaud's disease (a condition affecting blood flow to the extremities)
  • People whose blood circulation in certain areas is considered insufficient, based on the trial doctor's assessment
  • People who are pregnant, breastfeeding, or trying to become pregnant
  • People who are unwilling or unable to agree to the study's procedures
  • People with any other condition that the trial doctor considers would make participation unsuitable
  • People who are not willing to remove nail polish from their index finger
  • People who are not willing to remove facial make-up

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raf De Jongh, M.D., Complementair Medisch Centrum (CMC) Europe

Phone: +32 477 514 77

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pathway Medtech, LLC.
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
15 December 2025

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

SpO2 Accuracy (Arms)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov